Heart transplantation for chagas cardiomyopathy in the United States

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3262-3268

  Kransdorf, E P ^a   Czer, L S C ^a   Luthringer, D J ^a   Patel, J K ^a   Montgomery, S P ^b   Velleca, A ^a   Mirocha, J ^a   Zakowski, P C ^c   Zabner, R ^c   Gaultier, C R ^c   Qvarnstrom, Y ^b   Benedict, T ^b   Steurer, F ^b   Bosserman, E ^b   Paddock, C D ^b   Rafiei, M ^a   Kobashigawa, J A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Centers for Disease Control and Prevention ^*  (United States)

Author keywords

Cardiomyopathy; Chagas disease; Heart transplantation; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

ADULT; AGED; AMASTIGOTE; ARTICLE; BLOOD; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ALLOGRAFT DYSFUNCTION; HEART DISEASE; HEART EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; UNITED STATES;

CARDIOMYOPATHY; CHAGAS DISEASE; HEART TRANSPLANTATION; TRYPANOSOMA CRUZI;

ADULT; AGED; BELIZE; BIOPSY; CHAGAS CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EL SALVADOR; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; MALE; MEXICO; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECURRENCE; TRYPANOSOMA CRUZI; UNITED STATES;

EID: 84888387674     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12507     Document Type: Article

References (25)

1. Rassi A Jr., Rassi A, Marin-Neto JA., Chagas disease. Lancet 2010; 375: 1388-1402.
2. Freitas HF, Chizzola PR, Paes ÂT, Lima AC, Mansur AJ., Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: Role of Chagas' heart disease. Int J Cardiol 2005; 102: 239-247.
3. Kirchhoff LV., American trypanosomiasis (Chagas' disease)-A tropical disease now in the United States. N Engl J Med 1993; 329: 639-644.
4. Fiorelli AI, Santos RHB, Oliveira JL, et al. Heart transplantation in 107 cases of Chagas' disease. Trans Proc 2011; 43: 220-224.
5. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: Recommendations from the Chagas in Transplant Working Group. Am J Transplant 2011; 11: 672-680.
6. Bern C, Montgomery SP., An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49: e52-e54.
7. Cantey PT, Stramer SL, Townsend RL, et al. The United States Trypanosoma cruzi Infection Study: Evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012; 52: 1922-1930.
8. Stimpert KK, Montgomery SP., Physician awareness of Chagas disease, USA. Emerg Infect Dis 2010; 16: 871-872.
9. Bern C, Kjos S, Yabsley MJ, Montgomery SP., Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 2011; 24: 655-681.
10. Blanche C, Aleksic I, Takkenberg JJ, Czer LS, Fishbein MC, Trento A., Heart transplantation for Chagas' cardiomyopathy. Ann Thorac Surg 1995; 60: 1406-1408.
11. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: A systematic review. JAMA 2007; 298: 2171-2181.
12. Qvarnstrom Y, Schijman AG, Veron V, Aznar C, Steurer F, da Silva AJ., Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach. PLoS Negl Trop Dis 2012; 6: e1689.
13. Godoy HL, Guerra CM, Viegas RF, et al. Infections in heart transplant recipients in Brazil: The challenge of Chagas' disease. J Heart Lung Transplant 2010; 29: 286-290.
14. Ramírez JD, Guhl F, Umezawa ES, et al. Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods. J Clin Microbiol 2009; 47: 3945-3951.
15. WHO Expert Committee on the Control of Chagas Disease. Control of Chagas disease: Second report of the WHO expert committee. Geneva, Switzerland: World Health Organization, 2002, pp. 25-28.
16. Malan AK, Avelar E, Litwin SE, Hill HR, Litwin CM., Serological diagnosis of Trypanosoma cruzi: Evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. J Med Microbiol 2006; 55: 171-178.
17. Leiby DA, Herron RM Jr., Read EJ, Lenes BA, Stumpf RJ., Trypanosoma cruzi in Los Angeles and Miami blood donors: Impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-555.
18. Nowicki MJ, Chinchilla C, Corado L, et al. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: A population at risk. Transplantation 2006; 81: 477-479.
19. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48: 1534-1540.
20. Schwartz BS, Paster M, Ison MG, Chin-Hong PV., Organ donor screening practices for Trypanosoma cruzi infection among US organ procurement organizations. Am J Transplant 2011; 11: 848-851.
21. Campos SV, Strabelli TMV, Amato Neto V, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 2008; 27: 597-602.
22. Bacal F, Silva CP, Bocchi EA, et al. Mychophenolate mofetil increased Chagas disease reactivation in heart transplanted patients: Comparison between two different protocols. Am J Transplant 2005; 5: 2017-2021.
23. Bern C., Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 2011; 364: 2527-2534.
24. Fiorelli AI, Stolf NAG, Honorato R, et al. Later evolution after cardiac transplantation in Chagas' disease. Trans Proc 2005; 37: 2793-2798.
25. Bocchi EA, Fiorelli A;, First Guideline Group for Heart Transplantation of the Brazilian Society of Cardiology. The Brazilian experience with heart transplantation: A multicenter report. J Heart Lung Transplant 2001; 20: 637-645.